Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 1;28(11):770-777.
doi: 10.1097/SPV.0000000000001248. Epub 2022 Sep 24.

Underrepresentation in Pelvic Floor Disorder Patient-Reported Outcomes: Whose Outcomes Are We Measuring?

Julia K Shinnick  1 , Moiuri Siddique  1 , Spandana Jarmale  1 , Christina Raker  2 , Oluwateniola Brown  3 , Vivian W Sung  1 , Cassandra L Carberry  1
Affiliations

Underrepresentation in Pelvic Floor Disorder Patient-Reported Outcomes: Whose Outcomes Are We Measuring?

Julia K Shinnick et al. Urogynecology (Phila). .

Abstract

Importance: Patient-reported outcome (PRO) instruments measure the patient's perspective. It is unclear whether commonly used PRO measures were tested in populations that had racial and ethnic distributions comparable with those reported in U.S. census data.

Objective: The aim of this study was to compare the proportion of non-White race and Hispanic ethnicity participants with their expected proportion based on U.S. census data for PRO instruments with U.S.-based validation studies.

Study design: This was a retrospective review of PRO measures considered by the Pelvic Floors Disorders Consortium Working Group on Patient-Reported Outcomes in their 2020 consensus publication. Study and participant information were abstracted from PRO validation studies. Racial and ethnic representation in U.S.-based studies were compared with U.S. census data. The primary outcome was the representation quotient of reported races and ethnicities, calculated as the reported percentage of the study population identifying with a race and/or ethnicity divided by the proportion of the U.S. population identifying with that race and/or ethnicity when the study was published.

Results: Forty-five studies with 21,080 total participants were included. Race was reported in 17 of 45 studies (37.8%), and ethnicity was reported in 7 of 45 (15.6%). Most studies did not specify how race and ethnicity information was collected. For U.S.-based studies, the representation quotient of White participants from 1995 to 2019 was 1.15. Indigenous American/Native American/American Indian/Alaska Natives had the lowest representation quotient (0.22). Reporting of ethnicity increased over time (P = 0.001), although there was no significant change in the reporting of race or the representation of various races and ethnicities (P > 0.05).

Conclusion: Non-White and Hispanic patients may be underrepresented in U.S.-based validation studies for PRO instruments in pelvic floor disorders.

PubMed Disclaimer

Conflict of interest statement

The authors have declared they have no conflicts of interest.

Similar articles

See all similar articles

References

    1. U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 2006;4:79. doi:10.1186/1477-7525-4-79. - DOI
    1. Basch E. Patient-reported outcomes—harnessing patients' voices to improve clinical care. N Engl J Med 2017;376(2):105–108. doi:10.1056/NEJMp1611252. - DOI
    1. Bordeianou LG, Anger JT, Boutros M, et al; Members of the Pelvic Floor Disorders Consortium Working Groups on Patient-Reported Outcomes. Measuring pelvic floor disorder symptoms using patient-reported instruments: proceedings of the consensus meeting of the Pelvic Floor Consortium of the American Society of Colon and Rectal Surgeons, the International Continence Society, the American Urogynecologic Society, and the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction. Female Pelvic Med Reconstr Surg 2020;26(1):1–15. doi:10.1097/SPV.0000000000000817. - DOI
    1. Sung VW, Borello-France D, Newman DK, et al; NICHD Pelvic Floor Disorders Network. Effect of behavioral and pelvic floor muscle therapy combined with surgery vs surgery alone on incontinence symptoms among women with mixed urinary incontinence: the ESTEEM randomized clinical trial. JAMA 2019;322(11):1066–1076. doi:10.1001/jama.2019.12467. - DOI
    1. Nager CW, Visco AG, Richter HE, et al; NICHD Pelvic Floor Disorders Network. Effect of vaginal mesh hysteropexy vs vaginal hysterectomy with uterosacral ligament suspension on treatment failure in women with uterovaginal prolapse: a randomized clinical trial. JAMA 2019;322(11):1054–1065. doi:10.1001/jama.2019.12812. - DOI

LinkOut - more resources